2m 2m 2m 2m 2m 2m 2m
ALTO NEURO (ANRO)
NYSE
$27.08+$0.010 (+0.04%)
Price as of Aug 03, 2026 7:46 AM EDT- $1.1BMarket Cap
- 787.54%1-Year Change
- BiotechnologyIndustry
ALTO NEURO (ANRO)
$27.08+$0.010 (+0.04%)
ANRO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $27.07 | ||
Change | -$1.56 (-5.45%) | ||
Open | $28.50 | ||
High | $28.80 | ||
Low | $26.89 | ||
Previous Close | $28.63 | ||
Volume | 323,669 | ||
30-Day Average Volume | 564,070 | ||
1-Week Change | 1.08% | ||
1-Month Change | 2.58% | ||
1-Year Change | 787.54% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 38.9M | ||
Total Assets | $276.3M | ||
Market Cap | $1.1B | ||
Enterprise Value | $806.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$26.2M | ||
Free Cash Flow | -$27.6M | ||
EBIT | -$25.7M | ||
EBITDA | -$25.6M | ||
Net Working Capital | $256.0M | ||
EPS | -$0.80 | ||
Enterprise Value/EBITDA | -32 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -34 | ||
PEG | 0 | ||
Price/Free Cash Flow | -38 | ||
Price/Operating Cash Flow | -39 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue